Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
After Merkel cell carcinoma has been diagnosed more tests will be done to find out if cancer cells have spread from the place the cancer started to other parts of the body. The process used to find out whether the cancer has spread to other parts of the body is called staging. It is important to know the stage of the disease to plan the best treatment.
The following stages are used for Merkel cell carcinoma:
Stage 1: The primary tumor dimension is less than or equal to 2 cm without lymph node involvement.
Stage 2: The primary tumor is larger than 2 cm in maximum dimension but there is no lymph node involvement.
Stage 3: Regional lymph nodes are affected in Stage III or there is an in-transit metastasis.
Stage 4: The tumor has metastasized to any distant site outside of the regional lymph node distribution and/or internal organ (visceral) involvement.
Recurrent: Recurrent disease means that the cancer has recurred (come back) after it has been treated. It may come back in the same part of the body or in another part of the body.
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently recruiting participants or that may recruit participants in the near future. Closed trials are not currently enrolling, but similar studies may open in the future.